IDR: The Pharmaceutical Industry

György Bőgel, Vincent Edwards, Marian Wax, Tibor Benkő, János Hárskuti, Ildikó Király, Tibor Kovács, Tamás Szabó, Vilmos Szegő, Ervin Török and László Zentai

Chapter 9 in Hungary since Communism, 1997, pp 110-124 from Palgrave Macmillan

Abstract: Abstract The case study exemplifies a range of issues. The erosion of long-established relationships within the Hungarian pharmaceutical industry, coupled to a a substantial drop in state funding, has impelled the Institute for Drug Research (IDR) to rethink its traditional position and purpose. From being a predominantly research-oriented institute IDR has to become increasingly business-minded, seeking domestic and foreign customers willing to pay for its expertise.

Keywords: Pharmaceutical Market; Foreign Partner; Contract Research Organization; Hungarian Company; Ceutical Company (search for similar items in EconPapers)
Date: 1997
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-349-14201-9_9

Ordering information: This item can be ordered from
http://www.palgrave.com/9781349142019

DOI: 10.1007/978-1-349-14201-9_9

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().